Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 250,590 | 341,960 | 325,535 | 406,704 | 457,742 |
| Marketable Securities | 23,847 | 29,330 | 31,216 | 27,483 | 70,020 |
| Receivables | 41,021 | 33,762 | 29,648 | 23,296 | 18,910 |
| Inventories | 30,084 | 23,047 | 21,222 | 7,584 | 6,737 |
| Other current assets | 2,997 | 943 | 458 | 580 | 550 |
| TOTAL | $386,586 | $460,910 | $426,829 | $488,145 | $574,754 |
| Non-Current Assets | |||||
| PPE Net | 2,546 | 2,708 | 2,681 | 2,944 | 2,952 |
| Other Non-Current Assets | 14,389 | 20,356 | 30,620 | 28,922 | 26,586 |
| TOTAL | $16,935 | $23,064 | $33,301 | $31,866 | $29,538 |
| Total Assets | $403,521 | $483,974 | $460,130 | $520,011 | $604,292 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,718 | 9,066 | 9,934 | 12,643 | 12,521 |
| Accrued Expenses | 87,333 | 84,081 | 65,688 | 68,594 | 58,423 |
| Other current liabilities | 25,768 | 38,939 | 47,799 | 66,381 | 95,477 |
| TOTAL | $245,753 | $251,691 | $226,241 | $250,330 | $269,037 |
| Non-Current Liabilities | |||||
| Long Term Debt | 358,700 | 358,700 | 358,700 | 358,700 | 358,700 |
| Deferred Revenues | 117,231 | 117,231 | 100,564 | 100,564 | 100,564 |
| Other Non-Current Liabilities | 7,197 | 7,511 | 8,148 | 8,752 | 7,989 |
| TOTAL | $715,911 | $745,532 | $717,413 | $743,158 | $767,538 |
| Total Liabilities | $961,664 | $997,223 | $943,654 | $993,488 | $1,036,575 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 97,235 | 96,803 | 95,928 | 95,332 | 93,905 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,376,614 | -1,318,987 | -1,273,368 | -1,252,129 | -1,192,844 |
| Other shareholders' equity | -17,285 | -17,285 | -17,285 | -17,285 | -17,285 |
| TOTAL | $-558,143 | $-513,249 | $-483,524 | $-473,477 | $-432,283 |
| Total Liabilities And Equity | $403,521 | $483,974 | $460,130 | $520,011 | $604,292 |